PGI23 Cost-Effectiveness of Episodic or Maintenance Infliximab Versus Standard Treatment in an Incidence Cohort of Crohn's Disease Patients With 10-Years Follow-Up
Nov 1, 2012, 00:00
10.1016/j.jval.2012.08.772
https://www.valueinhealthjournal.com/article/S1098-3015(12)02485-0/fulltext
Title :
PGI23 Cost-Effectiveness of Episodic or Maintenance Infliximab Versus Standard Treatment in an Incidence Cohort of Crohn's Disease Patients With 10-Years Follow-Up
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)02485-0&doi=10.1016/j.jval.2012.08.772
First page :
A329
Section Title :
Gastrointestinal Disorders
Open access? :
No
Section Order :
282